Altria Group, Inc.

Altria Group, Inc. (MO) Market Cap

Altria Group, Inc. has a market capitalization of $115.16B.

Price: $68.97

-1.23 (-1.75%)

Market Cap: 115.16B

NYSE · time unavailable

CEO: William F. Gifford Jr.

Sector: Consumer Defensive

Industry: Tobacco

IPO Date: 1985-07-01

Website: https://www.altria.com

Altria Group, Inc. (MO) - Company Information

Market Cap: 115.16B|Sector: Consumer Defensive

Company Profile

Operating across the United States through its subsidiaries, Altria Group, Inc. is a prominent manufacturer and marketer of both combustible and oral tobacco items. Its portfolio features cigarettes, primarily under the iconic Marlboro brand, alongside cigars and pipe tobacco mainly offered as Black & Mild. The enterprise further provides an assortment of moist smokeless tobacco products, including Copenhagen, Skoal, Red Seal, and Husky, in addition to its on! brand of oral nicotine pouches. Altria distributes its merchandise chiefly to wholesale partners, such as independent distributors, and directly to substantial retail organizations, including major chain stores. The corporation, founded in 1822, maintains its principal offices in Richmond, Virginia.

Analyst Sentiment

69%
Buy

From 26 Active Polls

1Y Forecast: $71.83

▲ +4.2% Potential Upside

Consensus Target Metrics

Low Bound

$64

Median

$74

High Bound

$77

Average

$72

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$71.83
▲ +4.15% Upside
Low Target
$64.00
-7% Risk
Median Target
$73.50
7% Mid
High Target
$77.00
12% Max
Consensus
Buy
16 / 26 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)115,164110,40196,696111,24598,733101,43488,40486,92179,080
Enterprise Value ($M)136,235131,472117,931133,474122,166122,767110,203110,179102,304
Price to Earnings Ratio (P/E)14.3312.6421.6411.7110.3823.557.279.485.20
Price/Earnings-to-Growth Ratio (PEG)1.910.617.460.44
Price to Sales Ratio (P/S)5.2820.3416.5421.1918.6622.4517.3116.2714.99
Price to Book Ratio (P/B)-35.93-34.38-27.61-42.04-30.32-28.90-39.50-25.06-26.22
Price to Free Cash Flow Ratio (P/FCF)13.3649.4930.4236.59570.7137.8226.8533.69-760.38
Enterprise Value to Sales (EV/Sales)24.2220.1725.4223.0927.1721.5820.6219.39
Enterprise Value to EBITDA (EV/EBITDA)11.4941.4365.6338.9935.2760.9034.5232.7218.77
Debt to Equity Ratio1.78-7.66-7.34-9.71-7.59-7.42-11.14-7.25-8.30

MO Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$68.97
Intrinsic Value$84.02
Market Alignment
Undervalued by 21.8%relative to calculated intrinsic value
9.00%
Exp: -1%-1%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$11.27B
Perpetuity TV Value$212.01B
Discounted TV (PV)$89.56B
TV Weighting %57.2%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 ALTRIA GROUP INC (MO) — Investment Overview

🧩 Business Model Overview

Altria earns revenue by manufacturing and selling nicotine products through established channels in the United States, primarily cigarettes and smokeless tobacco (and related oral nicotine formats). The value chain is structured around (i) long-term procurement and handling of agricultural inputs (tobacco leaf), (ii) large-scale manufacturing and quality control, and (iii) a distribution network that reaches retailers, wholesalers, and other trade partners.

Consumer demand is characterized by habitual use and nicotine dependence, supporting repeat purchasing. From an economic standpoint, the model converts pricing, product mix, and cost discipline into operating cash flow, which then funds ongoing capital return and strategic investment/income from select holdings.

💰 Revenue Streams & Monetisation Model

Revenue is driven mostly by unit sales of cigarettes and smokeless nicotine products rather than by contract-based subscriptions. Monetisation occurs through the combination of:

  • Pricing and excise-tax pass-through: higher per-pack pricing and the ability to maintain net pricing after regulatory and tax effects.
  • Product mix: relative contribution of cigarettes versus smokeless formats, which can materially influence margins.
  • Input cost management: tobacco leaf costs, processing efficiency, and logistics.

Margin structure is primarily influenced by (i) manufacturing and operating cost intensity at scale, (ii) net pricing versus discounting and trade incentives, (iii) regulatory and legal cost burden, and (iv) the mix shift between cigarette categories and smokeless nicotine products.

A smaller portion of earnings can come from equity income and other investments, which typically behave like “non-operating monetisation” of capital rather than part of core product economics.

🧠 Competitive Advantages & Market Positioning

Altria’s moat is best understood as a blend of Switching Costs, Cost Advantages from Scale, and Regulatory/Legal Friction, reinforced by durable intangible assets (trade marks and consumer familiarity).

  • Switching costs / consumer stickiness: nicotine dependence and entrenched usage patterns create inertia. Competitors can win share, but moving consumers away from established formats generally requires sustained marketing and product adoption—often under a tightly regulated environment.
  • Cost advantages from scale: large manufacturing footprint, procurement know-how, and logistics capacity support lower unit costs and flexibility when input costs or demand shift.
  • Regulatory and legal moat: tobacco is heavily regulated and shaped by longstanding frameworks and enforcement. That creates high compliance and legal-risk costs that new entrants must overcome, limiting effective competition.
  • Intangible assets: brands/trademarks and product formulations support demand continuity and help maintain pricing power relative to generic alternatives.

COMPETITIVE BENCHMARKING:

  • Philip Morris International (PMI): global combustible focus outside the US, with heated-tobacco initiatives. Altria’s competitive emphasis is primarily the US market, where distribution structure and local regulatory dynamics differ.
  • British American Tobacco (BAT): global footprint with broad exposure to multiple nicotine categories and geographic diversification. Altria’s positioning is more US-centric, giving it stronger alignment with domestic channel economics and category mix dynamics.
  • Japan Tobacco (JT) (via ownership of tobacco assets in various markets): global scale but different regional regulatory frameworks and product strategies. Altria competes most directly on the US consumer franchise and local cost/scale efficiencies.

Across these rivals, the key contrast is geographic and channel focus: Altria’s advantage is the depth of its US operating system (manufacturing scale, distribution relationships, and regulatory familiarity) and its ability to manage category transitions within the nicotine market.

🚀 Multi-Year Growth Drivers

Tobacco is a mature market; durable returns tend to come from managing category shift and economic resilience rather than from rapid industry expansion. Over a 5–10 year horizon, growth drivers are typically centered on:

  • Share management within nicotine: maintaining share and net pricing in cigarettes while capturing resilience in smokeless nicotine categories where demand can be less volatile than combustibles.
  • Product evolution under regulation: developing and monetising nicotine alternatives to the extent permitted by regulatory pathways, with an emphasis on scale-ready manufacturing and distribution.
  • Operational efficiency: continuous cost actions in manufacturing, procurement, and logistics to offset volume pressure and input variability.
  • Capital allocation and shareholder yield: converting cash flow into sustained capital return, which can be a meaningful component of total return in mature consumer staples-like industries.

While long-term volumes may face secular headwinds from health policy and changing adult behavior, Altria’s potential for sustained value creation is tied to its ability to defend unit economics, manage mix, and adapt product platforms within the regulatory environment.

⚠ Risk Factors to Monitor

  • Regulatory risk (FDA/US state/federal actions): marketing authorization requirements, product standards, flavor restrictions, and other constraints can alter the viable product set and demand patterns.
  • Litigation and legal cost exposure: ongoing and future legal developments can pressure earnings and cash flows.
  • Excise taxes and pricing constraints: changes to tax policy can compress margins depending on the timing and degree of pass-through.
  • Illicit trade: revenue dilution and margin pressure can occur when counterfeit or untaxed products penetrate distribution channels.
  • Input cost volatility: tobacco leaf and related agricultural inputs can move through supply cycles, affecting cost of goods sold.
  • Category displacement: shifts toward regulated nicotine alternatives could reduce combustible demand faster than management assumptions, affecting long-term mix and earnings power.

📊 Valuation & Market View

Equity valuation for tobacco companies typically reflects durable cash generation, capital-return capacity, and the balance between pricing power and volume durability. Investors often benchmark using EV/EBITDA and earnings multiples where appropriate, but the fundamental market narrative usually centers on:

  • Free cash flow durability under regulatory and tax regimes
  • Net pricing trends and mix between cigarettes and smokeless formats
  • Legal and regulatory cost trajectory
  • Balance sheet and capital allocation (including dividend policy and buyback capacity)

Because the business is mature, multiple expansion typically requires evidence of sustained operating leverage and improved risk visibility, while downside risk often emerges from regulatory/legal shocks or faster-than-modeled category displacement.

🔍 Investment Takeaway

Altria’s long-term thesis rests on a resilient US nicotine operating system supported by consumer stickiness (switching inertia), scale-driven cost advantages, and regulatory/legal friction that increases barriers for effective competitive entry. The core challenge is navigating structural category change under stringent regulation; value creation depends on defending net pricing and mix, executing cost discipline, and adapting product strategy within permitted markets.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for MO.

zacks.com2026-06-17

Altria (MO) Suffers a Larger Drop Than the General Market: Key Insights

The latest trading day saw Altria (MO) settling at $68.97, representing a -1.75% change from its previous close.

247wallst.com2026-06-17

Why Own Rental Property When Dividend Income Can Pay You $10,000 a Month?

A $10,000 monthly income stream is one reason many investors gravitate toward rental real estate. It promises meaningful cash flow, but it also comes with tenants, maintenance, vacancies, insurance claims, and rising property taxes. A dividend portfolio offers a different path. The income arrives without late-night repair calls or the need to manage multiple properties.... Why Own Rental Property When Dividend Income Can Pay You $10,000 a Month?

zacks.com2026-06-17

Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know

Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

247wallst.com2026-06-17

The Exact Passive Income $20,000 Generates in High-Yield Dividend Stocks

Earned income disappears the moment you stop showing up. Dividend income does not.

fool.com2026-06-17

No Matter What Happens to the Market, These 3 Dividend Stocks Belong in Your Portfolio

Altria Group's business formula has worked for decades, and that's unlikely to change soon. Walmart will thrive as long as U.S. consumers continue to value low prices.

247wallst.com2026-06-16

$10,000 in This Dividend Stock Pays You More Than You'd Expect

Earned income is fragile. A layoff notice, a medical issue, or a sudden change in management can sever it overnight.

marketbeat.com2026-06-13

3 'Boring' Dividend Stocks With Tasty Technical Setups

Not every opportunity in the market needs to involve AI, rockets, or triple-digit revenue growth. Some of the most reliable returns come from the least exciting corners of the market: tobacco, pipelines, and single-tenant retail real estate.

247wallst.com2026-06-12

Up 33% From Its 52-Week Low: 1 Glaring Red Flag That Makes Altria Stock a Dangerous Buy at $73

Altria Group (NYSE:MO | MO Price Prediction) at $73.13 looks like a name to hold rather than add to.

zacks.com2026-06-11

Altria (MO) Stock Falls Amid Market Uptick: What Investors Need to Know

Altria (MO) reached $71.41 at the closing of the latest trading day, reflecting a -2.35% change compared to its last close.

247wallst.com2026-06-10

The Portfolio That Gets You a Waterfront Condo in Miami Beach

Ten thousand dollars a month in dividend income works out to $120,000 per year. That is enough to cover the rent on a luxury waterfront condo in Miami Beach, one of the most expensive rental markets in the country. The math that gets you there is simple: $120,000 divided by your portfolio yield equals the... The Portfolio That Gets You a Waterfront Condo in Miami Beach

247wallst.com2026-06-09

Earn $5,000+ Yearly With These 4 Dividend Stocks

Earned income has a ceiling. Hours in a day, headcount budgets, layoff cycles, and corporate restructurings all cap how much a paycheck can deliver.

zacks.com2026-06-09

Sin Stocks Under the Microscope: Risks, Returns & Reality

Sin stocks, including alcohol, tobacco, cannabis, firearms and gambling, draw investors' attention with steady demand and dividends, but ESG pressure, taxes and regulation are reshaping the risk/reward.

247wallst.com2026-06-08

Watch Out, Rising Capex Could Turn Today's Cash Cows Into Dogs

Pacer US Cash Cows 100 ETF (NYSEARCA:COWZ) owns the 100 Russell 1000 names that generate the most free cash flow relative to market value.

zacks.com2026-06-08

Altria (MO) Just Overtook the 20-Day Moving Average

Altria (MO) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MO broke through the 20-day moving average, which suggests a short-term bullish trend.

zacks.com2026-06-05

Altria (MO) Gains As Market Dips: What You Should Know

In the most recent trading session, Altria (MO) closed at $72.19, indicating a +2.25% shift from the previous trading day.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"MO reported Q1 2026 revenue of $5.43B and net income of $2.18B, with EPS of $1.30. Versus Q1 2025, revenue declined by ~+20.3%? (recomputed: $5.428B vs $4.519B = +20.1%) and net income increased by ~+102.5% ($2.183B vs $1.077B). On a QoQ basis, revenue fell ~-7.1% versus Q4 2025 ($5.43B vs $5.85B), while net income nearly doubled? (net income increased from $1.12B in Q4 to $2.18B in Q1, +95.6%). Profitability improved across the year: net margin rose to ~40.2% (from ~23.8% in Q1’25). However, Q4’25 vs Q1’26 net margin rose sharply (from ~19.1% to ~40.2%), indicating a significant improvement in operating profitability and/or tax/other line items in this quarter. Cash flow quality was strong: operating cash flow was $2.32B and free cash flow was $2.23B, supporting shareholder returns. Financing cash flows show continued shareholder payouts—dividends of $1.78B and buybacks of ~$0.28B in the quarter. Total shareholder returns appear solid given market momentum: the stock is up 12.05% over 1 year (below the >20% threshold), aligning with a generally constructive earnings backdrop. Valuation remains moderate vs consensus targets, with current price ($64.17) implying upside to the $63 consensus (roughly in-line) and a $65.5 median."

Revenue Growth

Positive

QoQ revenue declined ~-7.1% (Q1’26 $5.43B vs Q4’25 $5.85B). YoY revenue rose ~+20.1% (vs Q1’25 $4.52B), suggesting a strong year-over-year rebound despite some seasonality.

Profitability

Good

Net income increased ~+102.5% YoY ($2.18B vs $1.08B). Net margin improved to ~40.2% in Q1’26 (vs ~23.8% in Q1’25) and rose sharply vs QoQ (Q4’25 ~19.1% to Q1’26 ~40.2%).

Cash Flow Quality

Good

Operating cash flow was $2.32B and free cash flow $2.23B in Q1’26, supporting payouts. Dividends paid were $1.78B and buybacks were ~$0.28B, consistent with strong cash conversion in the quarter.

Leverage & Balance Sheet

Fair

Total assets were ~$34.6B in Q1’26. Leverage remains meaningful with long-term debt ~$48.7B and net debt ~$45.1B; equity is negative in reported totals, indicating ongoing balance-sheet strain typical for this historical reporting setup.

Shareholder Returns

Positive

Dividends remain a key component (dividend yield ~1.6% from ratios). Price momentum is positive but not “hot”: 1y_change is +12.05%, below the >20% momentum boost threshold.

Analyst Sentiment & Valuation

Neutral

Consensus target ($63) is roughly in-line with the current price ($64.17), with modest upside to the median ($65.5) and a wider range to the high/low ($74/$47).

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Altria started 2026 with adjusted diluted EPS up 7.3% and strong smokeable profitability, but management avoided raising guidance. The “beat” is framed primarily as moderation in cross-category movement between illicit/regulated vapor and cigarettes, supporting volumes and pricing; however, the company kept its full-year $5.56–$5.72 range citing gas-price and consumer-discretion uncertainty. Oral profitability softened: nicotine pouch investment and mix pressures drove oral OCI margins down 1.8 percentage points YoY despite >$400M segment adjusted OCI. Operationally, Helix accelerated on! PLUS nationwide rollout (shipping in March; ~100,000 stores by quarter-end; ~85% of category volume) with a trade program focused on ~90% of Helix volume. The key overhang remains e-vapor’s “upside down” marketplace, where ~70% of volume is illicit flavored disposables and progress depends on faster FDA authorization alongside enforcement.

AI IconGrowth Catalysts

  • on! oral nicotine pouches: category volume tailwind (oral industry +9.5% over 6 months) with nicotine pouch share now >58%
  • on! PLUS nationwide shipping began in March; available in ~100,000 stores by quarter-end (~85% of nicotine pouch category volume), supported by a new Helix retail trade program
  • FDA pilot program momentum: on! PLUS is authorized under PMTA pilot; management referenced FDA review timeline with expected authorization within the 180-day statutory window for certain SKUs
  • Early evidence of e-vapor category moderation consistent with increased enforcement and supply disruption; adult vapor estimates ~20.5M at end of March

Business Development

  • Helix launched a new retail trade program securing premium retail positioning in contracted stores representing ~90% of Helix volume
  • Additional retail shelf space discussion (Q&A): management characterized nicotine pouches as a distinct retail category, implying shelf space is primarily category-driven rather than taken from cigarette/other tobacco segments
  • Enforcement collaboration: federal agencies with local law enforcement, including a large-scale Northern Virginia action supported by the DEA

AI IconFinancial Highlights

  • Adjusted diluted EPS +7.3% in Q1 vs Q1 2025
  • Smokeable segment: adjusted OCI margins expanded to 65.1% (+0.7 percentage points) supported by net price realization +6.3% and stronger volume moderation effects; per-pack controllable costs benefited from higher volume/export mix
  • Smokeable volumes: reported domestic cigarette volumes -2.4%; trade-inventory adjusted shipment volumes -4% (decline continued moderation); 4th consecutive quarter of sequential moderation vs prior year
  • Oral tobacco: adjusted OCI >$400M; adjusted OCI margins 67.4% (-1.8 percentage points YoY) driven by Helix marketing investments (in-person/digital) and product mix (MST vs nicotine pouches)
  • Oral tobacco shipment trends: reported shipments -3.1% (on! growth offset by lower MST); trade-inventory adjusted volumes -~8.5%
  • Retail share: discount segment retail share +2.4 points YoY (driven by consumer trade-down under macro pressure); Marlboro premium share 59.5% (+0.1 YoY, +0.2 sequential)
  • Guidance reaffirmed: 2026 full-year adjusted diluted EPS $5.56 to $5.72 (growth 2.5% to 5.5% from $5.42 base); management emphasized growth balance between 1H/2H due to moderated cross-category movement

AI IconCapital Funding

  • Dividends paid: ~$1.8B in Q1
  • Share repurchases: 4.5M shares for ~$280M
  • Remaining authorization: ~$72M under current buyback program expiring end of year
  • Debt: retired just over $1B maturing in February; total debt-to-EBITDA at March 31 = 1.9x (in line with target)

AI IconStrategy & Ops

  • Helix execution: on! PLUS pipeline shipments and national rollout starting March; retail merchandising and signage strategy from curb-to-counter
  • Tradeoffs in Oral Tobacco profitability: Helix marketing investments and mix shift pressured oral OCI margins (-1.8 pp YoY)
  • e-vapor strategy framing: management anchored category recovery on FDA authorization process streamlining plus sustained enforcement
  • Marlboro product strategy: rollout of Marlboro “Cowboy Cut” later in 2Q; expected competitively priced (RGM tool) with variable price points by location

AI IconMarket Outlook

  • 2026 adjusted diluted EPS reaffirmed at $5.56–$5.72; management expects moderated labor industry growth impacts combustible and e-vapor volumes and highlights increased macro uncertainty for adult nicotine consumers
  • Phasing expectation: EPS growth balance between first half and second half primarily driven by moderation in cross-category movement and smokeable volume benefit (not by duty drawback timing alone)

AI IconRisks & Headwinds

  • Macro pressure on adult nicotine consumers: elevated gas prices and everyday expense inflation; management noted meaningful gas-price increase late in the quarter and ongoing pressure on discretionary spending
  • Trade-down dynamics favor discount cigarette segment (discount share growth +2.4 points YoY) while premium share is more resilient but still affected (Marlboro overall retail share -1.4 points YoY)
  • Oral segment profitability risk: Helix marketing investments and product mix (MST vs nicotine pouches) drove oral OCI margin decline (-1.8 pp YoY)
  • e-vapor marketplace remains “upside down”: ~70% of volume still illicit flavored disposables and category constrained by limited FDA-authorized products
  • Regulatory reliance: e-vapor and nicotine pouch approvals depend on FDA review outcomes; management referenced pilot program/PMTA timelines but still faces approval uncertainty

Q&A: Analyst Interest

  • Full-year guidance vs stronger Q1: Management said the positive surprise came from moderation in cross-category movement between vapor and cigarettes, which improved smokeable volume. Despite that, they reaffirmed to avoid overreacting to challenging macro and gas-price uncertainty and to observe whether offsets persist.
  • Cigarette volume composition and premium vs discount: Management tied discount-category growth to consumer trade-down under economic pressure, while premium resilience reflected Marlboro’s brand loyalty. They emphasized PM USA’s revenue growth management and total portfolio strategy enabling Basic to capture discount share without undermining Marlboro’s premium gains sequentially and YoY.
  • Duty drawback and EPS phasing drivers: Management expected rising export volumes and duty drawback benefits as the year progresses. However, they emphasized first-half/second-half EPS growth balance is mainly driven by moderated cross-category movement and consumer volume effects, with economic conditions (inflation/gas and IRS tax refunds) remaining the key uncertainty.

Sentiment: MIXED

Note: This summary was synthesized by AI from the MO Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for MO.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (MO)

© 2026 Stock Market Info — Altria Group, Inc. (MO) Financial Profile